
Join to View Full Profile
1300 Morris Park AvenueBronx, NY 10461
Dr. Steidl is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of Heidelberg Faculty of MedicineClass of 2000
Publications & Presentations
PubMed
- 9 citationsPI3-kinase deletion promotes myelodysplasia by dysregulating autophagy in hematopoietic stem cells.Kristina Ames, Imit Kaur, Yang Shi, Meng M Tong, Taneisha Sinclair
Science Advances. 2023-02-22 - 3 citationsLenalidomide and Eltrombopag for Treatment of Low- or Intermediate-Risk Myelodysplastic Syndrome: Result of a Phase II Clinical Trial.Jesus D Gonzalez-Lugo, Suman Kambhampati, Abdulraheem Yacoub, William B Donnellan, Jesus Berdeja
Clinical Cancer Research. 2023-01-04 - 1 citationsA glycan-based approach to cell characterization and isolation: Hematopoiesis as a paradigm.Richard T Piszczatowski, Emily Schwenger, Sriram Sundaravel, Catarina M Stein, Yang Liu
The Journal of Experimental Medicine. 2022-11-07
Abstracts/Posters
- SF3B1 Mutations Induce Oncogenic IRAK4 Isoforms and Activate Targetable Innate Immune Pathways in MDS and AMLUlrich G. Steidl, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Clinical ALK5 Inhibitor, Vactosertib, Reverses TGF_-1 Stimulated Smad-2 Driven Ineffective Hematopoiesis in MDSUlrich G. Steidl, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- High Burden of Clonal Hematopoiesis in First Responders Exposed to the World Trade Center DisasterUlrich G. Steidl, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Press Mentions
- Distinguished Cancer and Stem Cell Biologist Ulrich Steidl, M.D., Ph.D., Appointed Chair of Cell Biology at Albert Einstein College of MedicineNovember 22nd, 2022
- 8 Oncologists on the MoveApril 4th, 2022
- NCI-Designated Albert Einstein Cancer Center Announces Major Leadership ChangesMarch 30th, 2022
- Join now to see all
Grant Support
- Molecular and Cellular Regulation of Pre-Leukemic Stem Cells and their Therapeutic TargetingALBERT EINSTEIN COLLEGE OF MEDICINE2021–2028
- Molecular and Cellular Regulation of Pre-Leukemic Stem Cells and their Therapeutic TargetingALBERT EINSTEIN COLLEGE OF MEDICINE2021–2028
- Contribution of macrophages in the HSC nicheALBERT EINSTEIN COLLEGE OF MEDICINE2021–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: